Department of Critical Care Medicine, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Department of Infection Prevention and Control, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
BMC Infect Dis. 2020 Jan 6;20(1):8. doi: 10.1186/s12879-019-4724-6.
There have been no systematic studies of microbiological differences before and after antibiotics treatment. The aim of this study was to evaluate the effect of prior receipt of antibiotics on the microorganism distribution.
A retrospective, observational cohort study was conducted in a 3200-bed tertiary, referral, teaching hospital in eastern China. During a 2-year period, all hospitalized patients treated with antimicrobial agents were enrolled in this study. Among 48,692 patients evaluated, the 27,792 (57.1%) who were sampled within 2 days before or after administration of the first dose of antimicrobial agents were included. Distribution of clinical specimens and the microorganism were compared between before and after antibiotic drug treatment groups.
Compared to specimens taken after antibiotics exposure, specimens taken before antibiotics exposure had a higher proportion of blood and urine specimens and a higher culture positive rate (all P < 0.001). Higher percentages of Staphylococcus aureus (9.9% vs. 8.5%, P = 0.041), non-fermenting bacteria (27.7% vs. 19.9%, P < 0.001), and fungi (8.4% vs. 4.0%, P < 0.001) were isolated from the group after antibiotics exposure, while the percentages of Streptococcus spp. (4.8% vs. 2.7%, P < 0.001), Haemophilus influenzae (2.3% vs. 0.8%, P < 0.001), and Moraxella catarrhalis (0.7% vs. 0.1%, P < 0.001) were higher in the group before antibiotics exposure. Further analysis found significant differences of microbes derived from respiratory secretions, blood or urine samples. We found, after antibiotics exposure, the separation rate of non-fermenting bacteria was significantly increased (all P < 0.05), and the separation rate of Candida spp. was higher, with statistical significance in airway secretion and urine samples (both P < 0.05), but the separation rate of Staphylococcus aureus among the three groups was not affected by antibiotics. In addition, the isolation rate of Streptococcus spp. in blood and urine samples decreased significantly (both P < 0.05) after antibiotics exposure. Interestingly, no statistical difference was found for microbes isolated from body fluid specimens between the two groups.
The outcome revealed that antibiotic-insensitive organisms such as non-fermentative bacteria and fungi were more frequently isolated after antibiotics exposure. However, this trend might be specimen dependent and was not obvious in body fluid specimens.
目前尚无系统研究抗生素治疗前后微生物学差异的报道。本研究旨在评估既往抗生素使用对微生物分布的影响。
本研究为回顾性、观察性队列研究,在中国东部一家拥有 3200 张床位的三级转诊教学医院进行。在为期 2 年的时间里,所有接受抗菌药物治疗的住院患者均纳入本研究。在评估的 48692 例患者中,纳入了 27792 例(57.1%)在接受第一剂抗菌药物治疗前 2 天内或之后采集的样本。比较了抗生素治疗前后两组临床标本和微生物的分布。
与抗生素暴露后采集的标本相比,抗生素暴露前采集的标本血液和尿液标本比例更高,培养阳性率更高(均 P<0.001)。与抗生素暴露后采集的标本相比,抗生素暴露后采集的标本分离出的金黄色葡萄球菌(9.9%比 8.5%,P=0.041)、非发酵菌(27.7%比 19.9%,P<0.001)和真菌(8.4%比 4.0%,P<0.001)比例更高,而链球菌属(4.8%比 2.7%,P<0.001)、流感嗜血杆菌(2.3%比 0.8%,P<0.001)和卡他莫拉菌(0.7%比 0.1%,P<0.001)比例更高。进一步分析发现,来自呼吸道分泌物、血液或尿液样本的微生物有显著差异。我们发现,抗生素暴露后,非发酵菌的分离率显著增加(均 P<0.05),且气道分泌物和尿液样本中真菌的分离率更高(均 P<0.05),但三组之间金黄色葡萄球菌的分离率不受抗生素影响。此外,抗生素暴露后血液和尿液样本中链球菌属的分离率显著降低(均 P<0.05)。有趣的是,两组间体液标本中分离出的微生物无统计学差异。
结果表明,抗生素不敏感的微生物,如非发酵菌和真菌,在抗生素暴露后更常被分离出来。然而,这种趋势可能与标本有关,在体液标本中并不明显。